Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Osteoporosis – Prevention, Diagnosis and Treatment: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2003 Oct 14.

2.

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians.

Qaseem A, Forciea MA, McLean RM, Denberg TD; Clinical Guidelines Committee of the American College of Physicians.

Ann Intern Med. 2017 Jun 6;166(11):818-839. doi: 10.7326/M15-1361. Epub 2017 May 9. Erratum in: Ann Intern Med. 2017 Sep 19;167(6):448.

PMID:
28492856
3.
4.

Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Bell JM, Shields MD, Watters J, Hamilton A, Beringer T, Elliott M, Quinlivan R, Tirupathi S, Blackwood B.

Cochrane Database Syst Rev. 2017 Jan 24;1:CD010899. doi: 10.1002/14651858.CD010899.pub2. Review.

PMID:
28117876
5.

Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.

Kenanidis E, Potoupnis ME, Kakoulidis P, Leonidou A, Sakellariou GT, Sayegh FE, Tsiridis E.

Expert Opin Drug Saf. 2015 Jul;14(7):1035-53. doi: 10.1517/14740338.2015.1040387. Epub 2015 May 8. Review.

PMID:
25952267
6.

Efficacy, effectiveness and side effects of medications used to prevent fractures.

Reid IR.

J Intern Med. 2015 Jun;277(6):690-706. doi: 10.1111/joim.12339. Erratum in: J Intern Med. 2015 Sep;278(3):333.

7.

New strategies for osteoporosis patients previously managed with strontium ranelate.

Vestergaard P.

Ther Adv Musculoskelet Dis. 2014 Dec;6(6):217-25. doi: 10.1177/1759720X14552070. Review.

8.
9.

Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis.

Pereira RM, Carvalho JF, Paula AP, Zerbini C, Domiciano DS, Gonçalves H, Danowski JS, Marques Neto JF, Mendonça LM, Bezerra MC, Terreri MT, Imamura M, Weingrill P, Plapler PG, Radominski S, Tourinho T, Szejnfeld VL, Andrada NC; Committee for Osteoporosis and Bone Metabolic Disorders of the Brazilian Society of Rheumatology; Brazilian Medical Association; Brazilian Association of Physical Medicine and Rehabilitation.

Rev Bras Reumatol. 2012 Aug;52(4):580-93. English, Portuguese.

10.

Persistence and compliance of medications used in the treatment of osteoporosis--analysis using a large scale, representative, longitudinal German database.

Ziller V, Kostev K, Kyvernitakis I, Boeckhoff J, Hadji P.

Int J Clin Pharmacol Ther. 2012 May;50(5):315-22.

PMID:
22541835
11.

Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.

Murad MH, Drake MT, Mullan RJ, Mauck KF, Stuart LM, Lane MA, Abu Elnour NO, Erwin PJ, Hazem A, Puhan MA, Li T, Montori VM.

J Clin Endocrinol Metab. 2012 Jun;97(6):1871-80. doi: 10.1210/jc.2011-3060. Review.

PMID:
22466336
12.

Fracture prevention in postmenopausal women.

Vestergaard P, Mosekilde L, Langdahl B.

BMJ Clin Evid. 2011 May 3;2011. pii: 1109. Review.

13.

Review of osteoporosis pharmacotherapy for geriatric patients.

Gates BJ, Sonnett TE, Duvall CA, Dobbins EK.

Am J Geriatr Pharmacother. 2009 Dec;7(6):293-323. doi: 10.1016/j.amjopharm.2009.12.004. Review.

PMID:
20129253
14.

Vitamin K to prevent fractures in older women: systematic review and economic evaluation.

Stevenson M, Lloyd-Jones M, Papaioannou D.

Health Technol Assess. 2009 Sep;13(45):iii-xi, 1-134. doi: 10.3310/hta13450. Review.

15.

[Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].

Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, Klaushofer K; Austrian Society for Bone and Mineral Research (AuSBMR).

Wien Med Wochenschr Suppl. 2009;(122):1-34. doi: 10.1007/s10354-009-0656-x. German.

PMID:
19484202
16.

[New bisphosphonates and trends in drug therapy for osteoporosis: preface].

Matsumoto T.

Clin Calcium. 2009 Jan;19(1):9. No abstract available.

PMID:
19170268
17.

[New development in bisphosphonate treatment. Fracture prevention by bisphosphonates].

Hosoi T.

Clin Calcium. 2009 Jan;19(1):11-8. doi: CliCa09011118. Review. Japanese.

PMID:
19122260
18.

[Treatment of osteoporosis in the elderly: what is the evidence?].

Verhaar HJ.

Tijdschr Gerontol Geriatr. 2008 Oct;39(5):168-75. Dutch.

PMID:
18975841
19.

[Evidence and utility of etidronate for the treatment of osteoporosis].

Takada J, Iba K, Yamashita T, Yoshizaki T.

Clin Calcium. 2008 Oct;18(10):1427-33. doi: CliCa081014271433. Review. Japanese.

PMID:
18830039
20.

[Efficacy and tolerability of risedronate for the treatment of osteoporosis].

Kishimoto H.

Clin Calcium. 2008 Oct;18(10):1417-26. doi: CliCa081014171426. Review. Japanese.

PMID:
18830038

Supplemental Content

Loading ...
Support Center